Interestingly, using a dataset in a recent study of Ewing sarcoma patients from the Children's Oncology Group, we found that below-median expression of NKX2-2 correlates with decreased event-free survival (Fig. 7, p = 0.07) [65]. The gene discussed is NKX2-2; the disease is Ewing sarcoma.